JCM
ELV icon

Jacobi Capital Management’s Elevance Health ELV Stock Holding History

Jacobi Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Sell
1,180
-259
-18% -$96.1K 0.02% 468
2026
Q1 		$421K Sell
1,439
-192
-12% -$63.1K 0.02% 453
2025
Q4 		$572K Sell
1,631
-126
-7% -$42.6K 0.03% 379
2025
Q3 		$568K Buy
1,757
+446
+34% +$139K 0.03% 367
2025
Q2 		$510K Buy
1,311
+247
+23% +$99.3K 0.03% 376
2025
Q1 		$463K Buy
1,064
+182
+21% +$73.1K 0.03% 373
2024
Q4 		$325K Buy
882
+27
+3% +$11.3K 0.02% 455
2024
Q3 		$445K Buy
855
+189
+28% +$101K 0.03% 376
2024
Q2 		$361K Sell
666
-32
-5% -$16.9K 0.03% 374
2024
Q1 		$362K Buy
698
+13
+2% +$6.46K 0.03% 357
2023
Q4 		$323K Buy
685
+39
+6% +$18K 0.03% 359
2023
Q3 		$281K Buy
646
+17
+3% +$7.71K 0.03% 361
2023
Q2 		$280K Hold
629
– – 0.03% 367
2023
Q1 		$289K Sell
629
-9
-1% -$4.28K 0.03% 351
2022
Q4 		$327K Buy
638
+52
+9% +$26.4K 0.04% 326
2022
Q3 		$266K Hold
586
– – 0.04% 346
2022
Q2 		$283K Buy
586
+40
+7% +$19.8K 0.04% 341
2022
Q1 		$268K Sell
546
-1
-0.2% -$457 0.03% 361
2021
Q4 		$254K Buy
547
+25
+5% +$10.5K 0.03% 374
2021
Q3 		$195K Buy
522
+205
+65% +$77.9K 0.02% 397
2021
Q2 		$121K Buy
317
+32
+11% +$12.2K 0.02% 453
2021
Q1 		$102K Buy
285
+49
+21% +$15.8K 0.02% 451
2020
Q4 		$76K Buy
236
+38
+19% +$11.7K 0.01% 457
2020
Q3 		$53K Buy
198
+111
+128% +$29.9K 0.01% 487
2020
Q2 		$23K Buy
87
+53
+156% +$14.1K ﹤0.01% 616
2020
Q1 		$8K Sell
34
-15
-31% -$4.09K ﹤0.01% 740
2019
Q4 		$15K Buy
49
+47
+2,350% +$12.9K ﹤0.01% 675
2019
Q3 		$0 Hold
2
– – ﹤0.01% 1058
2019
Q2 		$1K Hold
2
– – ﹤0.01% 977
2019
Q1 		$1K Hold
2
– – ﹤0.01% 924
2018
Q4 		$1K Hold
2
– – ﹤0.01% 898
2018
Q3 		$1K Hold
2
– – ﹤0.01% 933
2018
Q2 		$0 Hold
2
– – ﹤0.01% 1022
2018
Q1 		$0 Buy
+2
New +$470 ﹤0.01% 991

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Jacobi Capital Management's ELV Position: Q2 2026 in Review

Jacobi Capital Management reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $96.1K and leaving 1,180 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #468.

Jacobi Capital Management first reported a position in ELV in Q1 2018 and has held it in 34 quarters since. The position peaked at $572K in Q4 2025. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Jacobi Capital Management held 1,180 shares of Elevance Health worth $456K as of Q2 2026.
  • Jacobi Capital Management sold 259 Elevance Health shares in Q2 2026, an estimated $96.1K.
  • Elevance Health made up 0.02% of Jacobi Capital Management's portfolio in Q2 2026, its #468 holding.
  • Jacobi Capital Management first reported a position in Elevance Health in Q1 2018 and has held it in 34 quarters since.
  • Jacobi Capital Management's Elevance Health position peaked at $572K in Q4 2025.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.